Saha, S.; Rundle, S.; Kotsopoulos, I.C.; Begbie, J.; Howarth, R.; Pappworth, I.Y.; Mukhopadhyay, A.; Kucukmetin, A.; Marchbank, K.J.; Curtin, N.
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy. Cancers 2022, 14, 4288.
https://doi.org/10.3390/cancers14174288
AMA Style
Saha S, Rundle S, Kotsopoulos IC, Begbie J, Howarth R, Pappworth IY, Mukhopadhyay A, Kucukmetin A, Marchbank KJ, Curtin N.
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy. Cancers. 2022; 14(17):4288.
https://doi.org/10.3390/cancers14174288
Chicago/Turabian Style
Saha, Santu, Stuart Rundle, Ioannis C. Kotsopoulos, Jacob Begbie, Rachel Howarth, Isabel Y. Pappworth, Asima Mukhopadhyay, Ali Kucukmetin, Kevin J. Marchbank, and Nicola Curtin.
2022. "Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy" Cancers 14, no. 17: 4288.
https://doi.org/10.3390/cancers14174288
APA Style
Saha, S., Rundle, S., Kotsopoulos, I. C., Begbie, J., Howarth, R., Pappworth, I. Y., Mukhopadhyay, A., Kucukmetin, A., Marchbank, K. J., & Curtin, N.
(2022). Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy. Cancers, 14(17), 4288.
https://doi.org/10.3390/cancers14174288